Investing Ideas
/
Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

10 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
500488 Abbott India	₹28,637.70	-0.07%	26.8%	₹608.5b	₹28,331.43	PE47.4x	E10.9%	1.4%
500420 Torrent Pharmaceuticals	₹3,434.25	2.6%	55.0%	₹1.2t	₹3,591.55	PE64.5x	E22.6%	0.8%
AJANTPHARM Ajanta Pharma	₹2,866.45	2.1%	45.6%	₹358.0b	₹2,973.91	PE40.9x	E16.4%	2.0%
NATCOPHARM NATCO Pharma	₹1,416.95	-1.7%	78.9%	₹253.8b	₹1,337.27	PE13x	E-20.1%	0.4%
INDSWFTLAB Ind-Swift Laboratories	₹107.11	-5.5%	10.4%	₹6.3b	n/a	PE1.7x	n/a	n/a
JSLL Jeena Sikho Lifecare	₹2,260.10	-3.8%	274.4%	₹56.2b	n/a	PE66.7x	n/a	0.2%
540737 Shree Ganesh Remedies	₹686.70	-7.3%	-1.0%	₹8.8b	n/a	PE31.7x	n/a	0%
524558 Neuland Laboratories	₹13,901.00	-9.2%	171.8%	₹178.3b	₹17,625.00	PE63.8x	E33.9%	0.1%
524632 Shukra Pharmaceuticals	₹101.78	40.0%	203.5%	₹4.5b	n/a	PE30.9x	n/a	1.0%
500126 Procter & Gamble Health	₹5,450.35	-4.0%	10.1%	₹90.5b	n/a	PE41.6x	E11.3%	2.2%

Page 1 of 1